Screening Sharply Improves Lung Cancer Long-term Survival
Findings from 20-year international study support low-dose CT screening for lung cancer detection
Diagnosing early-stage lung cancer with low-dose CT screening dramatically improves the long-term survival rate of cancer patients, according to a large-scale, 20-year international study published in Radiology.
The results show that patients diagnosed with lung cancer by low-dose CT screening have a 20-year survival rate of 81%. If diagnosed in the earliest Stage I, long-term survival was 95%.
“It is the first time that 20-year survival rates from annual screening have been reported,” said the study’s lead author, Claudia Henschke, PhD, MD, professor of radiology and director of the Early Lung and Cardiac Action Program at the Icahn School of Medicine at Mount Sinai in New York. “This 20-year survival rate of 81% is the estimated cure rate of all participants with lung cancers diagnosed by annual screening. This is a huge benefit compared to waiting for a diagnosis that, in usual care, is symptom-prompted.”
Lung cancer is the leading cause of cancer death. According to the American Lung Association, the average lung cancer five-year survival rate is 18.6%. Only 16% of lung cancers are diagnosed at an early stage, and more than half of people with lung cancer die within one year of being diagnosed.
While treatments of more advanced-stage cancers with targeted therapy and immunotherapy have come a long way, the best tool in the fight against cancer deaths is early diagnosis through low-dose CT screening before symptoms appear.
Since 1992, Dr. Henschke and colleagues have been studying the effectiveness of low-dose CT screening for lung cancer. This led to the creation of the International Early Lung Cancer Action Program (I-ELCAP) which has enrolled smore than 89,000 participants in over 80 institutions worldwide. This international program will continue its collaborations in 2024 with clinical and government organizations to roll out lung screening programs for underserved and low-income countries on two additional continents.
In 2006, the researchers identified a 10-year survival rate of 80% for the patients whose cancer was identified by CT screening. For this study, they looked at 20-year survival rates.“We were excited to see that the estimated cure rate we reported in 2006 has persisted after 20 years of follow-up,” Dr. Henschke said.
Earlier Detection Leads to Significantly Better Outcomes
The new study also found that among the 1,257 I-ELCAP participants diagnosed with lung cancer, 81% had Stage I disease. In this study, the long-term survival rate for Stage I cancers was 87%.
The findings demonstrate the importance of low-dose CT screening for early detection of lung cancer.
The researchers also included participants who have smoked less than 10 pack-years, including those who had never smoked cigarettes but had passive exposure to cigarette smoke.
“The less than 10 pack-years of smoking includes people who have never smoked,” Dr. Henschke said. “In the United States, some 25% of lung cancers are diagnosed in people who have never smoked.”
The results from this study show that after 20 years, patients diagnosed with lung cancer at an early stage via CT screening have significantly better outcomes. By treating the cancer when it is small, patients can be effectively cured in the long term.
“Lung cancer can be cured if you enroll in an annual screening program using a well-defined protocol and comprehensive management system,” Dr. Henschke said. “It is important to return for annual screening.”
The U.S. Preventive Services Task Force recommends annual lung cancer screening with low-dose CT in adults aged 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years.
For More Information
Access the Radiology study, “A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP),” and the related editorials, “Cure Rate of Lung Cancer Diagnosed at Annual CT Screening,” and “Twenty-year Progress in Lung Cancer Screening: A Marathon, Not a Sprint.”
Read previous RSNA News stories about lung cancer screening: